Over the next six years, the purchase and production of biosimilar drugs can expect to see high double-digit growth. Are you familiar with the trends driving growth in the hottest market in therapeutic development?
CDISC standards are now mandatory. Your organization can either treat them as another regulatory weight, or use them to mitigate risk, drive down costs, and increase efficiency.
Biorasi is not just a contract research organization. We are Clinical Research Optimized™, which means that we achieve the ideal balance of cost, time and risk management. Through innovative project management processes and technologies, dedication to our sponsors, and a culture of ownership, our team will deliver to you on time, on budget, results every time.
Clinical research is going global. This growth translates to sponsors no longer running separate studies in each and every country they are seeking marketing approval; instead they are opting for large, global studies that have percentages of the required subjects in...read more
For this week's Biorasi Spotlight, meet Phoevos Hughes, Senior Project Manager at Biorasi, LLC. 1. How did you get into clinical research? The short version – sheer luck. The long version… When I first decided that I had no interest in pursuing a legal career,...read more
The prevalence of Alzheimer’s disease (AD) is rapidly increasing as individual life spans across the world increase. It is currently the most common form of dementia, marked by the overproduction and aggregation of amyloid β (Aβ) and tau proteins in the brain. These...read more